PRITUMUMAB
UNII Z6Q90D1G53

Substance Identification & Data

This profile provides standardized clinical and technical data for Pritumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z6Q90D1G53.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 499212-74-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z6Q90D1G53
CAS Registry Number
499212-74-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PRITUMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8132
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pritumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PRITUMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G, ANTI-(HUMAN VIMENTIN) (HUMAN MONOCLONAL CLN G11 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CLN G11 .KAPPA.-CHAIN, DIMER
PRITUMUMAB [INN]

Technical Codes

ACA11
ACA-11
CLNH11
CLNH-11
CLNIGG
CLN-IGG